Interleukin-2 inhalation (Immunservice)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-2 inhalation (Immunservice)
Drug Alias NameBiomimetic inhaled IL-2Pulmoleukin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunservice
China Registration ClassN/A

Develop Information

Active CompaniesImmunservice
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeL03AC01
Related LinksN/A